BSE filing, NSE: SAMYAKINT. Summary written from the filing by ALFA Finder's alert engine.
Samyak International Ltd: key numbers
- Share price
- ₹21.45
- Market cap
- ₹17.15 Cr
- Revenue (annual)
- ₹42.26 Cr
- Net profit (annual)
- ₹0.24 Cr
- P/E (TTM)
- -16.1×Sector 43.1×
- Promoter holding
- 24.07%+1.72% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Samyak International Ltd
All →Samyak International Preferential Issue
Samyak International received BSE trading approval for 40,00,000 preferential equity shares, effective October 26, 2026. The shares were issued at Rs.17 each to promoters and non-promoter persons.
- Value
- ₹6.80 Cr
Samyak International Preferential Issue
The company allotted 4,000,000 equity shares and 4,000,000 warrants, both priced at Rs. 17 each. This preferential allotment raised Rs. 8.5 Crore in total consideration.
- Value
- ₹8.50 Cr
Samyak International Capital Structure Change
Samyak International received BSE listing approval for 40 lakh equity shares issued via preferential allotment at ₹17 per share.
- Value
- ₹6.80 Cr
Samyak International Capital Structure Change
Samyak International Limited shareholders approved increasing the authorized share capital to Rs. 25 Crore. This amendment to the Memorandum of Association was passed during the Annual General Meeting.
Samyak International Annual General Meeting
Samyak International Ltd held its 32nd Annual General Meeting on September 30, 2026, where members transacted business including financial statement adoption and authorized capital increases.
Samyak International Insolvency Petition
Samyak International has been declared the Successful Resolution Applicant for Shree Uttam Food Products under the IBC/CIRP process by the Committee of Creditors.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.